135 related articles for article (PubMed ID: 15678361)
1. Phencyclidine-induced impairment in attention and response control depends on the background genotype of mice: reversal by the mGLU(2/3) receptor agonist LY379268.
Greco B; Invernizzi RW; Carli M
Psychopharmacology (Berl); 2005 Apr; 179(1):68-76. PubMed ID: 15678361
[TBL] [Abstract][Full Text] [Related]
2. The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats.
Cartmell J; Monn JA; Schoepp DD
J Pharmacol Exp Ther; 1999 Oct; 291(1):161-70. PubMed ID: 10490900
[TBL] [Abstract][Full Text] [Related]
3. Tolerance to the motor impairment, but not to the reversal of PCP-induced motor activities by oral administration of the mGlu2/3 receptor agonist, LY379268.
Cartmell J; Monn JA; Schoepp DD
Naunyn Schmiedebergs Arch Pharmacol; 2000 Jan; 361(1):39-46. PubMed ID: 10651145
[TBL] [Abstract][Full Text] [Related]
4. mGluR2/3 agonist LY379268 rescues NMDA and GABAA receptor level deficits induced in a two-hit mouse model of schizophrenia.
Engel M; Snikeris P; Matosin N; Newell KA; Huang XF; Frank E
Psychopharmacology (Berl); 2016 Apr; 233(8):1349-59. PubMed ID: 26861891
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of specific PCP-evoked behaviors by the potent mGlu2/3 receptor agonist, LY379268 and comparison with the atypical antipsychotic, clozapine.
Cartmell J; Monn JA; Schoepp DD
Psychopharmacology (Berl); 2000 Mar; 148(4):423-9. PubMed ID: 10928316
[TBL] [Abstract][Full Text] [Related]
6. Effects of the mGlu2/3 receptor agonist LY379268 on motor activity in phencyclidine-sensitized rats.
Clark M; Johnson BG; Wright RA; Monn JA; Schoepp DD
Pharmacol Biochem Behav; 2002 Sep; 73(2):339-46. PubMed ID: 12117588
[TBL] [Abstract][Full Text] [Related]
7. Selective action of (-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY379268), a group II metabotropic glutamate receptor agonist, on basal and phencyclidine-induced dopamine release in the nucleus accumbens shell.
Greenslade RG; Mitchell SN
Neuropharmacology; 2004 Jul; 47(1):1-8. PubMed ID: 15165829
[TBL] [Abstract][Full Text] [Related]
8. A selective allosteric potentiator of metabotropic glutamate (mGlu) 2 receptors has effects similar to an orthosteric mGlu2/3 receptor agonist in mouse models predictive of antipsychotic activity.
Galici R; Echemendia NG; Rodriguez AL; Conn PJ
J Pharmacol Exp Ther; 2005 Dec; 315(3):1181-7. PubMed ID: 16123306
[TBL] [Abstract][Full Text] [Related]
9. The group II metabotropic glutamate receptor agonist (-)-2-oxa-4-aminobicyclo[3.1.0.]hexane-4,6-dicarboxylate (LY379268) and clozapine reverse phencyclidine-induced behaviors in monoamine-depleted rats.
Swanson CJ; Schoepp DD
J Pharmacol Exp Ther; 2002 Dec; 303(3):919-27. PubMed ID: 12438510
[TBL] [Abstract][Full Text] [Related]
10. Attention deficit induced by blockade of N-methyl D-aspartate receptors in the prefrontal cortex is associated with enhanced glutamate release and cAMP response element binding protein phosphorylation: role of metabotropic glutamate receptors 2/3.
Pozzi L; Baviera M; Sacchetti G; Calcagno E; Balducci C; Invernizzi RW; Carli M
Neuroscience; 2011 Mar; 176():336-48. PubMed ID: 21193020
[TBL] [Abstract][Full Text] [Related]
11. Interaction of mGlu2/3 agonism with clozapine and lurasidone to restore novel object recognition in subchronic phencyclidine-treated rats.
Horiguchi M; Huang M; Meltzer HY
Psychopharmacology (Berl); 2011 Sep; 217(1):13-24. PubMed ID: 21432027
[TBL] [Abstract][Full Text] [Related]
12. The mGlu(2/3) receptor agonist LY379268 selectively blocks amphetamine ambulations and rearing.
Cartmell J; Monn JA; Schoepp DD
Eur J Pharmacol; 2000 Jul; 400(2-3):221-4. PubMed ID: 10988337
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo evidence for a lack of interaction with dopamine D2 receptors by the metabotropic glutamate 2/3 receptor agonists 1S,2S,5R,6S-2-aminobicyclo[3.1.0]hexane-2,6-bicaroxylate monohydrate (LY354740) and (-)-2-oxa-4-aminobicyclo[3.1.0] Hexane-4,6-dicarboxylic acid (LY379268).
Fell MJ; Perry KW; Falcone JF; Johnson BG; Barth VN; Rash KS; Lucaites VL; Threlkeld PG; Monn JA; McKinzie DL; Marek GJ; Svensson KA; Nelson DL
J Pharmacol Exp Ther; 2009 Dec; 331(3):1126-36. PubMed ID: 19755662
[TBL] [Abstract][Full Text] [Related]
14. Phencyclidine and glutamate agonist LY379268 stimulate dopamine D2High receptors: D2 basis for schizophrenia.
Seeman P; Guan HC
Synapse; 2008 Nov; 62(11):819-28. PubMed ID: 18720422
[TBL] [Abstract][Full Text] [Related]
15. Effects of metabotropic glutamate receptor 2/3 agonism and antagonism on schizophrenia-like cognitive deficits induced by phencyclidine in rats.
Amitai N; Markou A
Eur J Pharmacol; 2010 Aug; 639(1-3):67-80. PubMed ID: 20371228
[TBL] [Abstract][Full Text] [Related]
16. Anti-epileptic activity of group II metabotropic glutamate receptor agonists (--)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY379268) and (--)-2-thia-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY389795).
Moldrich RX; Jeffrey M; Talebi A; Beart PM; Chapman AG; Meldrum BS
Neuropharmacology; 2001 Jul; 41(1):8-18. PubMed ID: 11445181
[TBL] [Abstract][Full Text] [Related]
17. Chronic treatment with a metabotropic mGlu2/3 receptor agonist diminishes behavioral response to a phenethylamine hallucinogen.
Halberstadt AL; van der Zee JVF; Chatha M; Geyer MA; Powell SB
Psychopharmacology (Berl); 2019 Feb; 236(2):821-830. PubMed ID: 30448990
[TBL] [Abstract][Full Text] [Related]
18. Evidence for the role of metabotropic glutamate (mGlu)2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2/3 receptor agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039).
Fell MJ; Svensson KA; Johnson BG; Schoepp DD
J Pharmacol Exp Ther; 2008 Jul; 326(1):209-17. PubMed ID: 18424625
[TBL] [Abstract][Full Text] [Related]
19. Lack of effect of LY314582 (a group 2 metabotropic glutamate receptor agonist) on phencyclidine-induced locomotor activity in metabotropic glutamate receptor 2 knockout mice.
Spooren WP; Gasparini F; van der Putten H; Koller M; Nakanishi S; Kuhn R
Eur J Pharmacol; 2000 May; 397(1):R1-2. PubMed ID: 10844118
[TBL] [Abstract][Full Text] [Related]
20. Blockade of serotonin 2A receptors prevents PCP-induced attentional performance deficit and CREB phosphorylation in the dorsal striatum of DBA/2 mice.
Pozzi L; Greco B; Sacchetti G; Leoni G; Invernizzi RW; Carli M
Psychopharmacology (Berl); 2010 Feb; 208(3):387-99. PubMed ID: 19997843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
